{
  "id": 275736,
  "title": "Radiopharmaceutical may benefit patients with metastatic prostate cancer sooner",
  "url": "https://urgent.news/2026/08/07/radiopharmaceutical-may-benefit-patients-with-metastatic-prostate",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-07T17:20:05.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-radiopharmaceutical-benefit-patients-metastatic-prostate.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Earlier use of a targeted radionuclide therapy delays metastatic prostate cancer progression when administered as part of a trio of drugs, according to a Phase III clinical trial led by Weill Cornell Medicine, NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and investigators at several other institutions worldwide.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}